Monte Rosa Therapeutics, Inc. (GLUE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.24
Day's range
$18.43

Monte Rosa Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 8.86 M $214.44 M   31.86% 13.52%
NEA MANAGEMENT COMPANY, LLC 08/14/2026 7.69 M $186.15 M   0.00% 11.74%
BLACKROCK, INC. 08/07/2026 6.84 M $165.60 M   21.38% 10.44%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 4.62 M $111.86 M   0.00% 7.05%
VESTAL POINT CAPITAL, LP 08/14/2026 4.60 M $111.32 M   27.65% 7.02%
BVF INC/IL 08/14/2026 4.46 M $107.95 M   0.00% 6.81%
BAKER BROS. ADVISORS LP 08/14/2026 4.35 M $105.17 M   0.00% 6.63%
STATE STREET CORP 08/07/2026 3.73 M $90.30 M   11.25% 5.69%
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 3.55 M $85.90 M   -16.02% 5.42%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.41 M $82.59 M   10.09% 5.21%
VERSANT VENTURE MANAGEMENT, LLC 08/12/2026 3.18 M $76.97 M   0.00% 4.85%
BRAIDWELL LP 08/14/2026 2.45 M $59.33 M   -23.55% 3.74%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.86 M $45.12 M   20.98% 2.84%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.62 M $39.27 M   -42.24% 2.48%
MARSHALL WACE, LLP 08/13/2026 1.59 M $38.57 M   11.20% 2.43%
AISLING CAPITAL MANAGEMENT LP 08/13/2026 1.56 M $37.65 M   0.00% 2.37%
BELLEVUE GROUP AG 08/14/2026 1.19 M $28.80 M   -4.80% 1.82%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.18 M $28.49 M   13.07% 1.80%
BIOIMPACT CAPITAL LLC 08/14/2026 1.16 M $28.10 M   -1.35% 1.77%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 1.11 M $26.82 M   -44.64% 1.69%
JUPITER TOPCO LLC 08/14/2026 1.07 M $25.97 M   100.00% 1.64%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 1.00 M $24.20 M   0.00% 1.53%
GOLDMAN SACHS GROUP INC 08/14/2026 998.25 K $24.16 M   -0.33% 1.52%
WOODLINE PARTNERS LP 08/14/2026 962.88 K $23.30 M   1,192.53% 1.47%
FMR LLC 08/13/2026 934.41 K $22.61 M   -8.78% 1.43%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 791.93 K $19.16 M   53.49% 1.21%
MORGAN STANLEY 08/13/2026 789.55 K $19.11 M   15.42% 1.20%
NEXTECH INVEST, LTD. 08/14/2026 761.15 K $18.42 M   150.18% 1.16%
OPALEYE MANAGEMENT INC. 08/14/2026 745.00 K $18.03 M   100.00% 1.14%
NORTHERN TRUST CORP 08/13/2026 652.09 K $15.78 M   -21.11% 0.99%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 651.99 K $15.78 M   0.00% 0.99%
FIRST TRUST ADVISORS LP 08/11/2026 647.80 K $15.68 M   100.00% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 616.31 K $14.91 M   12.74% 0.94%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 616.31 K $14.91 M   100.00% 0.94%
BOONE CAPITAL MANAGEMENT LLC 08/14/2026 615.29 K $14.89 M   100.00% 0.94%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 552.57 K $13.37 M   4.51% 0.84%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 520.65 K $12.60 M   -20.93% 0.79%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 505.50 K $12.23 M   24.18% 0.77%
PARKWOOD LLC 08/14/2026 505.00 K $12.22 M   0.00% 0.77%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 450.00 K $10.89 M   80.00% 0.69%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 405.53 K $9.81 M   1,168.19% 0.62%
AMERIPRISE FINANCIAL INC 08/14/2026 383.34 K $9.28 M   964.91% 0.58%
ALPHABET INC. 08/07/2026 372.47 K $9.01 M   -45.57% 0.57%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 363.52 K $8.80 M   15.45% 0.55%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 08/13/2026 352.86 K $8.54 M   -10.04% 0.54%
EMPOWERED FUNDS, LLC 08/17/2026 329.27 K $7.97 M   7.82% 0.50%
CAPTION MANAGEMENT, LLC 08/14/2026 300.00 K $7.26 M   100.00% 0.46%
DUQUESNE FAMILY OFFICE LLC 08/14/2026 297.60 K $7.20 M   100.00% 0.45%
TD ASSET MANAGEMENT INC 08/04/2026 285.94 K $6.92 M   -0.36% 0.44%
BANK OF AMERICA CORP /DE/ 08/14/2026 254.56 K $6.16 M   -34.31% 0.39%

Monte Rosa Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 230 institutional investors and hedge funds held shares of Monte Rosa Therapeutics Inc. The most heavily invested institutionals were:

PRICE T ROWE ASSOCIATES INC /MD/: 8.86 M

NEA Management Company, LLC: 7.69 M

BlackRock, Inc.: 6.84 M

TCG Crossover Management, LLC: 4.62 M

Vestal Point Capital, LP: 4.6 M

BVF INC/IL: 4.46 M

142.23% of Monte Rosa Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 99.71 M shares in the last 24 months. This purchase volume represents approximately $1.76 B in transactions.